Solara Active Pharma Sciences Limited (BOM:541540)
India · Delayed Price · Currency is INR 551.50
+1.15 (0.21%)
At close: Dec 5, 2025
BOM:541540 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
Net Income | 64.1 | 5.4 | -5,674 | -221.8 | -581.5 | 2,214 | Upgrade |
Depreciation & Amortization | 951.4 | 974.8 | 1,011 | 1,066 | 1,081 | 1,056 | Upgrade |
Other Amortization | 17.7 | 17.7 | 21.9 | 46.1 | 41.9 | 30.9 | Upgrade |
Loss (Gain) From Sale of Assets | -0.5 | - | 19.7 | 4.5 | 7.7 | -20 | Upgrade |
Asset Writedown & Restructuring Costs | 0.8 | 0.8 | 25.3 | - | - | - | Upgrade |
Stock-Based Compensation | 40.5 | 26.8 | 6 | 0.5 | -13.1 | 51.4 | Upgrade |
Provision & Write-off of Bad Debts | 20.9 | 10.2 | 109.9 | 56.6 | 88.2 | - | Upgrade |
Other Operating Activities | 917.4 | 1,062 | 3,662 | 603.4 | 93.1 | 281 | Upgrade |
Change in Accounts Receivable | 404.7 | 198.1 | 1,782 | -528 | -145.5 | -2,574 | Upgrade |
Change in Inventory | -789.9 | 418 | 130.8 | 173.2 | -2,806 | -152.4 | Upgrade |
Change in Accounts Payable | 108.2 | -594.3 | 73 | 389 | -238.8 | 966.7 | Upgrade |
Change in Other Net Operating Assets | 132.9 | 8.4 | -79.2 | -26.8 | 52.2 | -299 | Upgrade |
Operating Cash Flow | 1,868 | 2,128 | 1,089 | 1,563 | -2,420 | 1,555 | Upgrade |
Operating Cash Flow Growth | 53.65% | 95.48% | -30.32% | - | - | -35.80% | Upgrade |
Capital Expenditures | -487.7 | -399.4 | -410.6 | -1,113 | -2,086 | -1,745 | Upgrade |
Sale of Property, Plant & Equipment | 4.6 | 3.8 | 10.4 | 13 | 1.3 | 29.7 | Upgrade |
Cash Acquisitions | -0.1 | - | - | - | - | - | Upgrade |
Divestitures | 9.6 | 9.6 | - | - | - | - | Upgrade |
Investment in Securities | -9.6 | - | - | -12.8 | - | -1 | Upgrade |
Other Investing Activities | 20.3 | 17.7 | 41.6 | 125 | -343.6 | 653.1 | Upgrade |
Investing Cash Flow | -462.9 | -368.3 | -35.1 | -811.4 | -2,429 | -1,063 | Upgrade |
Short-Term Debt Issued | - | - | 1,115 | 394.4 | 2,487 | 68.2 | Upgrade |
Long-Term Debt Issued | - | 750 | 49 | 683 | 2,624 | 1,558 | Upgrade |
Total Debt Issued | 750 | 750 | 1,164 | 1,077 | 5,111 | 1,626 | Upgrade |
Short-Term Debt Repaid | - | -1,854 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -1,131 | -1,194 | -1,331 | -962.2 | -2,654 | Upgrade |
Total Debt Repaid | -2,752 | -2,985 | -1,194 | -1,331 | -962.2 | -2,654 | Upgrade |
Net Debt Issued (Repaid) | -2,002 | -2,235 | -30.2 | -253.1 | 4,149 | -1,028 | Upgrade |
Issuance of Common Stock | 1,582 | 1,590 | - | - | 29 | 2,982 | Upgrade |
Common Dividends Paid | - | - | - | - | -107.8 | -197.3 | Upgrade |
Other Financing Activities | -1,007 | -1,160 | -1,026 | -874.5 | -734 | -831.9 | Upgrade |
Financing Cash Flow | -1,427 | -1,805 | -1,057 | -1,128 | 3,336 | 924.9 | Upgrade |
Net Cash Flow | -22.1 | -44.9 | -2.9 | -376.5 | -1,513 | 1,417 | Upgrade |
Free Cash Flow | 1,381 | 1,729 | 678.1 | 449.4 | -4,507 | -190.2 | Upgrade |
Free Cash Flow Growth | 58.57% | 154.95% | 50.89% | - | - | - | Upgrade |
Free Cash Flow Margin | 11.45% | 13.47% | 5.26% | 3.11% | -35.53% | -1.18% | Upgrade |
Free Cash Flow Per Share | 41.94 | 43.33 | 17.75 | 12.48 | -125.38 | -5.54 | Upgrade |
Cash Interest Paid | 1,007 | 1,131 | 1,035 | - | 734 | 831.9 | Upgrade |
Cash Income Tax Paid | 23.1 | 9 | -9 | -135.4 | 181 | 333.6 | Upgrade |
Levered Free Cash Flow | 374.65 | 595.65 | 2,768 | -82.46 | -5,069 | -957.98 | Upgrade |
Unlevered Free Cash Flow | 968.09 | 1,279 | 3,402 | 460.04 | -4,616 | -455.85 | Upgrade |
Change in Working Capital | -144.1 | 30.2 | 1,906 | 7.4 | -3,138 | -2,058 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.